APP and Alzheimer disease: The release of amyloidogenic β-amyloid (Aβ) as a result of the β-amyloid precursor protein (APP) proteolytic processing causes Alzheimer’s Disease (AD) [1], which belongs to the group of human amyloid diseases [2].